COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street's first-quarter expectations, as the drugmaker's profit grew 61 percent.
Source: daily mail – mail online
Summary automatically generated by NewSUM A.I. from the following sources:
- Pfizer profits rocket by 61% to $7.86B in the first quarter (daily mail – mail online)
- Pfizer profit soars in first quarter, revises 2022 forecast (washington times)